Literature DB >> 6601996

The role of interleukin 1 and interleukin 2 in human T colony formation.

B Klein, A Rey, M Jourdan, B Serrou.   

Abstract

We investigated the roles of interleukin 1 (IL1) and interleukin 2 (IL2) on T colony formation by PHA-stimulated peripheral blood lymphocytes (PBL). Purified T cells stimulated by PHA could not generate T colonies as did PBL. Media conditioned by PHA-stimulated PBL (PHA-LCM) contained IL2 and a T colony-promoting activity (TCPA) which induced T colony formation in PHA-stimulated purified T cells. IL2 and TCPA are coeluted in the same peak of 18,000 molecular weight after gel filtration chromatography. Moreover, TCPA present in the PHA-LCM could be absorbed on IL2-sensitive cells which possessed specific receptors for IL2. These results suggest that TCPA and IL2 are related entities. Monocytes or IL1 (a monokine released by activated monocytes) also induced T colony formation in purified T cells. Phorbol myristate acetate (PMA) could replace monocytes in the induction of T colony. Monocytes, IL1, or PMA are known to be crucial requirements for IL2 production by PHA-stimulated T cells. This combined with the fact that IL2 participates in T colony formation suggests that monocytes induce T colony formation through IL2 production.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601996     DOI: 10.1016/0008-8749(83)90035-7

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  8 in total

1.  The effects of interleukins and other soluble factors on T-lymphocyte colony formation.

Authors:  A Winkelstein; P L Simon; D Wood; L L Machen; R K Shadduck; A Waheed
Journal:  Immunology       Date:  1986-06       Impact factor: 7.397

2.  Relationship between IL-2 and human T cell colony formation.

Authors:  M D Mossalayi; J C Lecron; J Tanzer; P Goube de Laforest
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

3.  Identification and purification of human T-lymphocyte colony-enhancing factor, TLCEF: increased production by phorbol myristate acetate.

Authors:  M M Werber; J Goldman; J Radnay; S Klein; L A Rozenszajn
Journal:  Immunology       Date:  1985-10       Impact factor: 7.397

4.  Control of human T-colony formation by interleukin-2.

Authors:  M Jourdan; T Commes; B Klein
Journal:  Immunology       Date:  1985-02       Impact factor: 7.397

5.  The defect in peripheral blood B-cell activation in patients with multiple myeloma is not due to a deficiency in the production of B-cell growth and differentiation factors.

Authors:  T Commes; B Klein; M Jourdan; G Clofent; F Houssiau; J Grenier; R Bataille
Journal:  J Clin Immunol       Date:  1989-01       Impact factor: 8.317

6.  Production of interleukin 2 in multiple myeloma.

Authors:  T Commes; B Klein; M Jourdan; R Bataille
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

7.  The role of interleukin-2 in T colony formation by human pre-T cells (pTCFC).

Authors:  A Rey; B Klein; C Ilnicki; M Jourdan; B Serrou
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

8.  Comparison of phorbol myristate acetate and phytohaemagglutinin as stimulators of in vitro T lymphocyte colony formation of human peripheral blood lymphocytes. I. Surface markers of colony cells.

Authors:  T Suzawa; S Hyodo; T Kishi; H Kashiwa; T Karakawa; E Kittaka; T Sakano; T Usui
Journal:  Immunology       Date:  1984-11       Impact factor: 7.397

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.